Skip to content

Comparison of the effects of a combination of platelet-rich plasma and laser therapy versus a combination of platelet-rich plasma, laser therapy, and exercise therapy on pain intensity, disability, and quality of life in patients with knee osteoarthritis: a clinical trial study

Comparison of the effects of a combination of platelet-rich plasma and laser therapy versus a combination of platelet-rich plasma, laser therapy, and exercise therapy on pain intensity, disability, and quality of life in patients with knee osteoarthritis: a clinical trial study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201001048893N4
Enrollment
72
Registered
2022-07-03
Start date
2024-08-21
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting i

Interventions

Intervention 1: The first intervention group: In this group, PRP injection will be done five times in the amount of 3 ml (two weeks apart) in the patients knee. The centrifuge device manufactured by N

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Mild to moderate osteoarthritis (OA) (2 or 3) as diagnosed by an orthopedic surgeon based on the Kellgren-Lawrence Grading Scale (KL) No inflammatory and bleeding disorders No rheumatoid arthritis No endocrine and metabolic diseases Imbalance and limping No pregnancy not perform procedures such as Arthrocentesis in the last six months No joint surgery last year Willingness to participate in the study

Exclusion criteria

Exclusion criteria: Failure to complete the course of treatment Participant withdrawal from the study

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Before treatment and 1, 3, and 6 months after treatment. Method of measurement: Numerical Rating Scale (NRS).

Secondary

MeasureTime frame
Disability. Timepoint: Before treatment and 1, 3, and 6 months after treatment. Method of measurement: The Western Ontario and McMaster Universities Arthritis Index (WOMAC).;Quality of life. Timepoint: Before treatment and 3, and 6 months after treatment. Method of measurement: 36-Item Short Form Survey (SF-36).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Shaygan

Shiraz University of Medical Sciences

m2620.shaygan@gmail.com0098 71 36474255-221

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026